Laboratorio Reig Jofre S A : Reig Jofre convenes its 2024 General Shareholders´ Meeting
March 08, 2024 at 05:53 am EST
Share
Reig Jofre convenes its 2024 General Shareholders´ Meeting
8 March 2024
Reig Jofre reports that on 28 February 2024, the Board of Directors of the Company was held, which approved the convening of the Ordinary and Extraordinary General Shareholders' Meeting on 10 April 2024, at 11:00 am on first call and in the same location and at the same time on the following day, 11 April 2024 on second call, if necessary, with the agenda attached hereafter.
The Board of Directors has also agreed to enable remote attendance at the Ordinary and Extraordinary General Meeting of Shareholders, allowing those shareholders who so wish to attend and participate in the General Meeting by remote connection and in real time, in accordance with the provisions of the Articles of Association and the Regulations of the General Meeting of Shareholders.
Download the full document (PDF)
Documentation available to the shareholder
Attachments
Original Link
Permalink
Disclaimer
Laboratorio Reig Jofre SA published this content on
08 March 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
08 March 2024 10:52:04 UTC.
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Companyâs activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
LABORATORIO REIG JOFRE, S.A. 
